Journal of Clinical Medicine (Apr 2024)

Exploring the Associations of Inflammatory and Oxidative Stress Biomarkers with Pancreatic Diseases: An Observational and Mendelian Randomisation Study

  • Laura Vilà-Quintana,
  • Esther Fort,
  • Laura Pardo,
  • Maria T. Albiol-Quer,
  • Maria Rosa Ortiz,
  • Montserrat Capdevila,
  • Anna Feliu,
  • Anna Bahí,
  • Marc Llirós,
  • Esther Aguilar,
  • Adelaida García-Velasco,
  • Mireia M. Ginestà,
  • Berta Laquente,
  • Débora Pozas,
  • Aleix Lluansí,
  • Ville Nikolai Pimenoff,
  • Victor Moreno,
  • Libadro Jesús Garcia-Gil,
  • Eric J. Duell,
  • Robert Carreras-Torres,
  • Xavier Aldeguer

DOI
https://doi.org/10.3390/jcm13082247
Journal volume & issue
Vol. 13, no. 8
p. 2247

Abstract

Read online

Identifying biomarkers linked to pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP) is crucial for early detection, treatment, and prevention. Methods: Association analyses of 10 serological biomarkers involved in cell signalling (IFN-γ, IL-6, IL-8, IL-10), oxidative stress (superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzyme activities, total glutathione (GSH), malondialdehyde (MDA) levels), and intestinal permeability proteins (zonulin, I-FABP2) were conducted across PDAC (n = 12), CP (n = 21) and control subjects (n = 23). A Mendelian randomisation (MR) approach was used to assess causality of the identified significant associations in two large genetic cohorts (FinnGen and UK Biobank). Results: Observational results showed a downregulation of SOD and GPx antioxidant enzyme activities in PDAC and CP patients, respectively, and higher MDA levels in CP patients. Logistic regression models revealed significant associations between CP and SOD activity (OR = 0.21, 95% CI [0.05, 0.89], per SD), GPx activity (OR = 0.28, 95% CI [0.10, 0.79], per SD), and MDA levels (OR = 2.05, 95% CI [1.36, 3.08], per SD). MR analyses, however, did not support causality. Conclusions: These findings would not support oxidative stress-related biomarkers as potential targets for pancreatic diseases prevention. Yet, further research is encouraged to assess their viability as non-invasive tools for early diagnosis, particularly in pre-diagnostic CP populations.

Keywords